Pure erythroid leukemia
Abstract Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing >80% of marrow cellularity, with ≥30% proerythroblasts.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-12-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.3316 |
| _version_ | 1818650075176370176 |
|---|---|
| author | Méghan Forest Simon F. Roy Michelle Houde Antonio Maietta |
| author_facet | Méghan Forest Simon F. Roy Michelle Houde Antonio Maietta |
| author_sort | Méghan Forest |
| collection | DOAJ |
| description | Abstract Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing >80% of marrow cellularity, with ≥30% proerythroblasts. |
| first_indexed | 2024-12-17T01:44:27Z |
| format | Article |
| id | doaj.art-bb2285d33bd14fc28912384bb86e9ce8 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-12-17T01:44:27Z |
| publishDate | 2020-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-bb2285d33bd14fc28912384bb86e9ce82022-12-21T22:08:13ZengWileyClinical Case Reports2050-09042020-12-018123597359810.1002/ccr3.3316Pure erythroid leukemiaMéghan Forest0Simon F. Roy1Michelle Houde2Antonio Maietta3Department of Pathology University of Montréal Montréal QC CanadaDepartment of Pathology University of Montréal Montréal QC CanadaDepartment of Pathology University of Montréal Montréal QC CanadaDepartment of Pathology University of Montréal Montréal QC CanadaAbstract Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing >80% of marrow cellularity, with ≥30% proerythroblasts.https://doi.org/10.1002/ccr3.3316AMLbone marrow pathologyhematological oncologypancytopeniapure erythroid leukemia |
| spellingShingle | Méghan Forest Simon F. Roy Michelle Houde Antonio Maietta Pure erythroid leukemia Clinical Case Reports AML bone marrow pathology hematological oncology pancytopenia pure erythroid leukemia |
| title | Pure erythroid leukemia |
| title_full | Pure erythroid leukemia |
| title_fullStr | Pure erythroid leukemia |
| title_full_unstemmed | Pure erythroid leukemia |
| title_short | Pure erythroid leukemia |
| title_sort | pure erythroid leukemia |
| topic | AML bone marrow pathology hematological oncology pancytopenia pure erythroid leukemia |
| url | https://doi.org/10.1002/ccr3.3316 |
| work_keys_str_mv | AT meghanforest pureerythroidleukemia AT simonfroy pureerythroidleukemia AT michellehoude pureerythroidleukemia AT antoniomaietta pureerythroidleukemia |